Dr. Michael Bageac, MD

Dr. Bageac practices at Barnabas Health Medical Group in West Orange, New Jersey.

Dr. Bageac's NPI, 1811984701, was assigned on October 5, 2005. Dr. Bageac graduated from Carol Davila University of Medicine and Pharmacy in 1982. Dr. Bageac holds New Jersey license 25MA04993200.

Dr. Bageac's primary practice is Barnabas Health Medical Group, at 95 Old Short Hills Rd, West Orange, NJ 07052 in Essex County. The practice phone is (973) 322-4921.

Dr. Bageac's primary practice is Barnabas Health Medical Group in West Orange, New Jersey. Dr. Bageac is also affiliated with Community Medical Center. The medical group on file is RWJBarnabas Health Medical Group. Dmand AI also links Dr. Bageac to 2 more group practices and clinics and 1 medical group, each named with a free account.

Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Bageac practices, 3 sites in all. Vendor and product names are available with a free account.

Cardiovascular disease is Dr. Bageac's primary specialty in the NPI Registry, under taxonomy code 207RC0000X. Dr. Bageac is board certified in cardiovascular disease by the American Board of Internal Medicine. Dr. Bageac is licensed in New Jersey.

Dmand AI lists aneurysm, atrial fibrillation and flutter, cardiomyopathy, cerebrovascular disease, chronic hypertension, coronary artery disease, deep vein thrombosis (DVT) and heart blockage among the conditions Dr. Bageac treats.

CMS data shows 4,964 Medicare services from Dr. Bageac across 9 procedure codes in 2024, for 1,539 Medicare patients. Medicare paid $175,413 for them.

CMS counts 1,539 Medicare patients who saw Dr. Bageac in 2024. The largest group is 75 to 84, with 619 patients. 75% of them have high blood pressure, and 75% have high cholesterol. 10% are also on Medicaid. Their average risk score is 1.70, where 1.00 is the Medicare average, so they are sicker than most Medicare patients.

Across all payers, Dmand AI patient panel data puts Dr. Bageac's median patient age at 75, with 52% women.

In 2024, Dr. Bageac wrote 7,269 Medicare Part D claims for 951 patients. 88% of them were for generic drugs. CMS names the drug for 6,958 of them, across 70 drugs with 11 or more claims each, at $1,169,862 in total drug cost. In 2023, CMS named 6,697 claims across 71 drugs.

CMS publishes a Merit-based Incentive Payment System (MIPS) score of 99 out of 100 for Dr. Bageac for performance year 2024, reported through an alternative payment model (APM). Dr. Bageac accepts Medicare assignment, so Medicare's approved amount is taken as full payment.

CMS Open Payments shows 315 general payments to Dr. Bageac from 30 drug and device companies from 2016 to 2025. Food and beverage make up the largest share, 99% of the total. Janssen Pharmaceuticals, Inc paid the most, $949.

Dmand AI lists 1 award for Dr. Bageac.

Dr. Bageac graduated from Carol Davila University of Medicine and Pharmacy in 1982. Dr. Bageac is a member of ACC.

Dr. Bageac is in network with 19 carriers, including Aetna, Elevance and Horizon Blue Cross Blue Shield of New Jersey. PPO plans come from the most carriers, 13. Check the plan with the practice before a visit.